
Cancer vaccine shows promise in preventing recurrence of pancreatic, colorectal tumors
Fox News
An experimental vaccine keeps a majority of high-risk pancreatic and colorectal cancer patients disease-free for nearly 20 months in a UCLA study.
"The new cancer vaccine from UCLA is very promising as a major tool against these cancers." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
The patients had all undergone surgery to remove tumors and showed "signs of minimal residual disease" or traces of DNA, putting them at a high risk of recurrence, according to a UCLA press release.
More Related News













